Cargando…
An Update on the HIV DNA Vaccine Strategy
In 2020, the global prevalence of human immunodeficiency virus (HIV) infection was estimated to be 38 million, and a total of 690,000 people died from acquired immunodeficiency syndrome (AIDS)–related complications. Notably, around 12.6 million people living with HIIV/AIDS did not have access to lif...
Autores principales: | Hokello, Joseph, Sharma, Adhikarimayum Lakhikumar, Tyagi, Mudit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226902/ https://www.ncbi.nlm.nih.gov/pubmed/34198789 http://dx.doi.org/10.3390/vaccines9060605 |
Ejemplares similares
-
Circumcision as an Intervening Strategy against HIV Acquisition in the Male Genital Tract
por: Sharma, Adhikarimayum Lakhikumar, et al.
Publicado: (2021) -
Efficient Non-Epigenetic Activation of HIV Latency through the T-Cell Receptor Signalosome
por: Hokello, Joseph, et al.
Publicado: (2020) -
Combinatorial Use of Both Epigenetic and Non-Epigenetic Mechanisms to Efficiently Reactivate HIV Latency
por: Hokello, Joseph, et al.
Publicado: (2021) -
Insights into the HIV Latency and the Role of Cytokines
por: Hokello, Joseph, et al.
Publicado: (2019) -
Comparison of the Biological Basis for Non-HIV Transmission to HIV-Exposed Seronegative Individuals, Disease Non-Progression in HIV Long-Term Non-Progressors and Elite Controllers
por: Hokello, Joseph, et al.
Publicado: (2023)